The frequency of positive nuclear PATZ1 expression decreased as the dedifferentiation of thyroid cancer progressed, and the frequency of nuclear PATZ1 expression in ATC was significantly decreased compared to that in NT/AG, DTC (i.e., PTC and FTC), or PDTC. This evidence concerns the gene PATZ1 and thyroid cancer.